Epidemiological Investigation of Iranian Patients with Pulmonary Embolism Based on Medication

Abstract

Background: The primary cause of mortality in pulmonary embolism (PE) is believed to be the lack of emergency treatment. Objectives: This study aimed to assess the outcomes of primary treatment and evaluate complications based on the type of medication used in Iranian PE patients after hospital discharge. Methods: This retrospective study was conducted on 108 PE patients admitted to Shohada Tajrish Hospital, Tehran, Iran, during 2018 - 2019. Clinical manifestations, treatment methods, drug-related complications, and prognosis were analyzed within six months post-discharge. Results: A significant association was observed between underlying diseases and the mortality rate (P < 0.05). The frequency of prescribed medications in PE patients was as follows: 60% for rivaroxaban, 9% for apixaban, 14% for warfarin, and 17.5% for enoxaparin. No significant correlation was found between death, bleeding, and the type of drug used. Conclusions: The increased mortality rate in PE patients is strongly associated with underlying conditions, such as cancer. The use of anticoagulants significantly reduces mortality rates in PE patients.

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By